AR016161A1 - Procedimiento para preparar un hidrato de la sal de acido maleico de 5-[4- [2-(n-metil-n(2-piridil)amino)etoxi]bencil]tiazolidina-2,4-diona. - Google Patents
Procedimiento para preparar un hidrato de la sal de acido maleico de 5-[4- [2-(n-metil-n(2-piridil)amino)etoxi]bencil]tiazolidina-2,4-diona.Info
- Publication number
- AR016161A1 AR016161A1 ARP980106368A ARP980106368A AR016161A1 AR 016161 A1 AR016161 A1 AR 016161A1 AR P980106368 A ARP980106368 A AR P980106368A AR P980106368 A ARP980106368 A AR P980106368A AR 016161 A1 AR016161 A1 AR 016161A1
- Authority
- AR
- Argentina
- Prior art keywords
- provides
- amino
- methyl
- maleic acid
- hydrate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Un procedimiento para preparar un hidrato de la sal de ácido maleico de 5-[4-[2-(N-metil-N-(2-piridil)amino)etoxil]bencil]tiazolidina-2,4-diona, dondedicho hidrato: (i) comprende agua en el intervalo de 0,3 a 0,6 equivalentes molares; y (ii)proporciona un espectro infrarrojo que contiene picos a 1757,1331, 1290, 1211 y 767 cm-1, y/o (iii) proporciona un espectro Raman que contiene picos a 1758, 1610, 1394, 1316 y 1289 cm-1; y/o (iv)proporciona unespectro de resonancia magnética nuclear en estado solido que contiene desplazamientos químicos sustancialmente como se indica en la tabla I; (v)proporciona una imagen de difraccion en polvo de rayos X (XRPD) sustancialmente como se indica en la figura IV que el procedimiento comprende cristalizar lasal de ácido maleico de 5-[4-[2-(N-metil-N-(2-piridil)amino)etoxi]bencil] tiazolidina-2,4-diona en etanol acuoso. El compuesto (I) se describeexclusivamente como una forma anhidra. Se ha descubierto ahora que el compuesto(I) existe en una nueva forma hidratada que es particularmente adecuada parapreparacion y manipulacion a granel. Esta forma puede prepararse por un procedimiento eficiente, economico y reproducible particularmente adecuado parala preparacionen gran escala. El nuevo hidrato tiene también propiedades farmacéuticas utiles y se indica en particular que es util para el tratamientoy/o la profilaxis de diabetes mellitus, condiciones asociadas con diabetes mellitus y ciertas complicaciones de la misma.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9726563.1A GB9726563D0 (en) | 1997-12-16 | 1997-12-16 | Novel pharmaceutical |
Publications (1)
Publication Number | Publication Date |
---|---|
AR016161A1 true AR016161A1 (es) | 2001-06-20 |
Family
ID=10823691
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980106364A AR017211A1 (es) | 1997-12-16 | 1998-12-15 | Hidrato de la sal de acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi/bencil/tiazolidina-2,4-diona, procedimiento para su preparacion,composicion farmaceutica y el uso de dicho hidrato para la fabricacion de medicamentos |
ARP980106368A AR016161A1 (es) | 1997-12-16 | 1998-12-15 | Procedimiento para preparar un hidrato de la sal de acido maleico de 5-[4- [2-(n-metil-n(2-piridil)amino)etoxi]bencil]tiazolidina-2,4-diona. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980106364A AR017211A1 (es) | 1997-12-16 | 1998-12-15 | Hidrato de la sal de acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi/bencil/tiazolidina-2,4-diona, procedimiento para su preparacion,composicion farmaceutica y el uso de dicho hidrato para la fabricacion de medicamentos |
Country Status (37)
Country | Link |
---|---|
US (4) | US20020133016A1 (es) |
EP (1) | EP1042321A1 (es) |
JP (1) | JP2002508371A (es) |
KR (1) | KR100549141B1 (es) |
CN (3) | CN1285831A (es) |
AP (1) | AP1363A (es) |
AR (2) | AR017211A1 (es) |
AU (2) | AU2272299A (es) |
BG (1) | BG64850B1 (es) |
BR (1) | BR9813598A (es) |
CA (1) | CA2314967A1 (es) |
CO (1) | CO4990943A1 (es) |
CZ (1) | CZ300081B6 (es) |
DZ (1) | DZ2679A1 (es) |
EA (1) | EA002833B1 (es) |
EG (1) | EG22250A (es) |
GB (1) | GB9726563D0 (es) |
HR (1) | HRP20000404A2 (es) |
HU (1) | HUP0102292A3 (es) |
ID (1) | ID24714A (es) |
IL (2) | IL160847A0 (es) |
MA (1) | MA26581A1 (es) |
MY (1) | MY128573A (es) |
NO (1) | NO317255B1 (es) |
NZ (1) | NZ504703A (es) |
OA (1) | OA11900A (es) |
PE (1) | PE20000125A1 (es) |
PL (1) | PL341213A1 (es) |
RS (1) | RS50080B (es) |
SA (1) | SA99200200B1 (es) |
SK (1) | SK286422B6 (es) |
TR (2) | TR200001793T2 (es) |
TW (1) | TW487709B (es) |
UA (1) | UA66821C2 (es) |
UY (2) | UY25306A1 (es) |
WO (1) | WO1999031093A1 (es) |
ZA (1) | ZA9811504B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
US6664278B2 (en) | 1997-12-16 | 2003-12-16 | Smithkline Beecham P.L.C. | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
GB9726568D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
GB9909041D0 (en) * | 1999-04-20 | 1999-06-16 | Smithkline Beecham Plc | Novel pharmaceutical |
US20040248945A1 (en) | 1999-04-23 | 2004-12-09 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
CO5170421A1 (es) | 1999-04-23 | 2002-06-27 | Smithkline Beecham Plc | Nuevo compuesto farmaceutico maleico |
HUP0200929A3 (en) | 1999-04-23 | 2004-03-29 | Smithkline Beecham Plc | Thiazolidinedione derivative and its use as antidiabetic and process for preparation thereof |
JP2002543076A (ja) * | 1999-04-23 | 2002-12-17 | スミスクライン ビーチャム パブリック リミテッド カンパニー | チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用 |
GB0014005D0 (en) * | 2000-06-08 | 2000-08-02 | Smithkline Beecham Plc | Novel pharmaceutical |
GB0021784D0 (en) * | 2000-09-05 | 2000-10-18 | Smithkline Beecham Plc | Novel pharmaceutical |
GB0021978D0 (en) * | 2000-09-07 | 2000-10-25 | Smithkline Beecham Plc | Novel pharmaceutical |
GB0129876D0 (en) * | 2001-12-13 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
AU2002350965A1 (en) * | 2001-12-13 | 2003-06-23 | Smithkline Beecham Plc | Toluenesulfonate hydrates of a thiazolidinedione derivative |
KR100450700B1 (ko) * | 2002-03-22 | 2004-10-01 | 주식회사종근당 | 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물 |
EP1468997A3 (en) * | 2003-04-18 | 2004-11-03 | CHEMI S.p.A. | Polymorphous forms of rosiglitazone maleate |
GB2405403A (en) * | 2003-08-29 | 2005-03-02 | Cipla Ltd | Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base |
EP1841414A1 (en) * | 2003-12-31 | 2007-10-10 | Alpharma, Inc. | Rosiglitazone and metformin formulations |
EP1732513A2 (en) * | 2003-12-31 | 2006-12-20 | Alpharma, Inc. | Rosiglitazone formulations |
ITMI20041537A1 (it) * | 2004-07-28 | 2004-10-28 | Chemi Spa | Nuova forma polimorfa del rosiglitazone maleato |
CZ298424B6 (cs) * | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel |
US7435741B2 (en) | 2006-05-09 | 2008-10-14 | Teva Pharmaceutical Industries, Ltd. | 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
EP2184055A1 (en) | 2008-11-07 | 2010-05-12 | LEK Pharmaceuticals d.d. | Process for preparing solid dosage forms of rosiglitazone maleate |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3856378T2 (de) | 1987-09-04 | 2000-05-11 | Beecham Group P.L.C., Brentford | Substituierte Thiazolidindionderivate |
US6288095B1 (en) | 1987-09-04 | 2001-09-11 | Beecham Group P.L.C. | Compounds |
GB8820389D0 (en) * | 1988-08-26 | 1988-09-28 | Beecham Group Plc | Novel compounds |
GB9124513D0 (en) * | 1991-11-19 | 1992-01-08 | Smithkline Beecham Plc | Novel process |
US5741803A (en) | 1992-09-05 | 1998-04-21 | Smithkline Beecham Plc | Substituted thiazolidinedionle derivatives |
GB9218830D0 (en) | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
DE4404198A1 (de) | 1994-02-10 | 1995-08-17 | Henkel Kgaa | 2-Fluor-6-nitroaniline |
EP0777469A1 (en) * | 1994-02-10 | 1997-06-11 | Smithkline Beecham Plc | Use of insulin sensitisers for treating renal diseases |
US6664278B2 (en) | 1997-12-16 | 2003-12-16 | Smithkline Beecham P.L.C. | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
PL360661A1 (en) | 2000-09-26 | 2004-09-20 | Dr.Reddy's Research Foundation | Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
-
1997
- 1997-12-16 GB GBGB9726563.1A patent/GB9726563D0/en not_active Ceased
-
1998
- 1998-12-14 MA MA25391A patent/MA26581A1/fr unknown
- 1998-12-14 PL PL98341213A patent/PL341213A1/xx not_active Application Discontinuation
- 1998-12-14 AU AU22722/99A patent/AU2272299A/en not_active Abandoned
- 1998-12-14 EP EP98966320A patent/EP1042321A1/en not_active Withdrawn
- 1998-12-14 UA UA2000063483A patent/UA66821C2/uk unknown
- 1998-12-14 HU HU0102292A patent/HUP0102292A3/hu unknown
- 1998-12-14 ID IDW20001128A patent/ID24714A/id unknown
- 1998-12-14 IL IL16084798A patent/IL160847A0/xx unknown
- 1998-12-14 BR BR9813598-8A patent/BR9813598A/pt not_active Application Discontinuation
- 1998-12-14 CZ CZ20002206A patent/CZ300081B6/cs not_active IP Right Cessation
- 1998-12-14 KR KR1020007006514A patent/KR100549141B1/ko not_active IP Right Cessation
- 1998-12-14 CN CN98812091A patent/CN1285831A/zh active Pending
- 1998-12-14 CN CNA2008100919932A patent/CN101318957A/zh active Pending
- 1998-12-14 TR TR2000/01793T patent/TR200001793T2/xx unknown
- 1998-12-14 NZ NZ504703A patent/NZ504703A/xx unknown
- 1998-12-14 RS YUP-364/00A patent/RS50080B/sr unknown
- 1998-12-14 OA OA00000177A patent/OA11900A/en unknown
- 1998-12-14 EA EA200000656A patent/EA002833B1/ru not_active IP Right Cessation
- 1998-12-14 IL IL13642598A patent/IL136425A/en unknown
- 1998-12-14 JP JP2000539017A patent/JP2002508371A/ja not_active Withdrawn
- 1998-12-14 SK SK918-2000A patent/SK286422B6/sk not_active IP Right Cessation
- 1998-12-14 CN CNA2008100919928A patent/CN101318956A/zh active Pending
- 1998-12-14 CA CA002314967A patent/CA2314967A1/en not_active Abandoned
- 1998-12-14 AP APAP/P/2000/001829A patent/AP1363A/en active
- 1998-12-14 WO PCT/EP1998/008153 patent/WO1999031093A1/en active IP Right Grant
- 1998-12-15 AR ARP980106364A patent/AR017211A1/es unknown
- 1998-12-15 DZ DZ980289A patent/DZ2679A1/xx active
- 1998-12-15 UY UY25306A patent/UY25306A1/es unknown
- 1998-12-15 UY UY25309A patent/UY25309A1/es not_active IP Right Cessation
- 1998-12-15 MY MYPI98005673A patent/MY128573A/en unknown
- 1998-12-15 ZA ZA9811504A patent/ZA9811504B/xx unknown
- 1998-12-15 EG EG155398A patent/EG22250A/xx active
- 1998-12-15 AR ARP980106368A patent/AR016161A1/es not_active Application Discontinuation
- 1998-12-16 CO CO98074832A patent/CO4990943A1/es unknown
- 1998-12-16 TW TW087121120A patent/TW487709B/zh not_active IP Right Cessation
- 1998-12-16 TR TR1998/02624A patent/TR199802624A2/xx unknown
- 1998-12-16 PE PE1998001231A patent/PE20000125A1/es not_active Application Discontinuation
-
1999
- 1999-05-31 SA SA99200200A patent/SA99200200B1/ar unknown
-
2000
- 2000-06-15 NO NO20003070A patent/NO317255B1/no not_active IP Right Cessation
- 2000-06-16 HR HR20000404A patent/HRP20000404A2/hr not_active Application Discontinuation
- 2000-07-13 BG BG104606A patent/BG64850B1/bg unknown
-
2002
- 2002-02-08 US US10/071,339 patent/US20020133016A1/en not_active Abandoned
- 2002-03-20 AU AU27538/02A patent/AU770818B2/en not_active Ceased
-
2003
- 2003-01-30 US US10/354,365 patent/US20030139604A1/en not_active Abandoned
-
2005
- 2005-08-17 US US11/205,426 patent/US20050288513A1/en not_active Abandoned
-
2006
- 2006-09-28 US US11/536,313 patent/US7368574B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR016161A1 (es) | Procedimiento para preparar un hidrato de la sal de acido maleico de 5-[4- [2-(n-metil-n(2-piridil)amino)etoxi]bencil]tiazolidina-2,4-diona. | |
AR017214A1 (es) | Un proceso para preparar un hidrato de la sal del acido maleico de 5-[4[2-(n-metil-n-(2-piridil)amino)-etoxi]bencil]tiazolidin-2,4-diona | |
BR0009934A (pt) | Produto farmacêutico | |
UY25310A1 (es) | Procedimiento para preparar un hidrato de la sal de ácido 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4 diona maleico | |
UY26121A1 (es) | Nuevo compuesto farmacéutico | |
PE20010045A1 (es) | Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidin-2,4-diona | |
AR023567A1 (es) | Un procedimiento para preparar un monohidrato de hidrocloruro derivado de la tiazolidin-2,4-diona | |
EA200101101A1 (ru) | Новый фармацевтический препарат | |
HK1057751A1 (en) | A thiazolidinedione derivative and its use as antidiabetic | |
ECSP982781A (es) | Hidrato de la sal de maleico de 5-[4- (-n -metil-n- (2-piridil) amino) etoxi) bensil) tiazolidina - 2,4 diona | |
NZ524933A (en) | Sodium salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical composition thereof | |
ECSP003436A (es) | Nuevos compuestos | |
TH84544A (th) | ไฮเดรทชนิดใหม่ | |
TH13935EX (th) | การเตรียมสารปฏิชีวนะกลุ่มเซฟาโลสพอริน โดยใช้ syn-ไอโซเมอร์ของไธอะไซลิล อินเทอร์มิเดียท | |
ECSP003438A (es) | Nuevos compuestos | |
ECSP003437A (es) | Nuevos compuestos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |